Quantitative and functional analysis of PDC‐E2‐specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
While the pathologic mechanisms responsible for organ-specific tissue damage in primary biliary cirrhosis (PBC) remain an enigma, it has been suggested that the pathology is mediated by autoreactive T cells infiltrating the intrahepatic bile ducts. Previously, we have documented that there is 100-fold enrichment in the frequency of CD4+ autoreactive T cells in the liver that are specific for peptides encoded by the E2 components of the pyruvate dehydrogenase complexes (PDC-E2). We have also recently characterized the first MHC class I–restricted epitope for PDC-E2, namely amino acid 159–167, a region very similar to the epitope recognized by MHC class II–restricted CD4+ cells and by autoantibodies. The effector functions of these PDC-E2159-167–specific CD8+ cytotoxic T lymphocytes (CTLs) are not well understood. We have taken advantage of tetramer technology and report herein that there is tenfold increase in the frequency of PDC-E2159-167–specific CTLs in the liver as compared with the blood in PBC. In addition, the precursor frequency of the CTLs in blood was significantly higher in early-stage PBC. Of interest was the fact that, upon stimulation with the peptide, the response of PDC-E2159-167 tetramer-positive cells is heterogeneous with respect to IFN-γ synthesis. These data, we believe for the first time, document the enrichment of autoantigen-specific CD8+ T cells in the PBC liver, suggesting that CD8+ T cells play a significant role in the immunopathogenesis of PBC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129 · cited 1×
“Dendritic cells (DCs) were generated from PBMCs of HLA-A*0201–positive donors as described (18) and used as antigen-presenting cells (APCs).”
MethodPhenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“PDC-E2159-167-HLA A2 tetramers were generated as described (17).”
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
Lee, P. P., Yee, C., Savage, P. A., Fong, L., Brockstedt, D., Weber, J. S., Johnson, D., Swetter, S., Thompson, J., Greenberg, P. D., et al. (1999) · Nature Medicine · doi:10.1038/9525 · Cited by 1,113
Callan, M. F. C., Tan, L., Annels, N., Ogg, G. S., Wilson, J. D. K., O'Callaghan, C. A., Steven, N., McMichael, A. J., & Rickinson, A. B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1395 · Cited by 892
Garboczi, D. N., Hung, D. T., & Wiley, D. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3429 · Cited by 689
A Pathogenic Role for Myelin-Specific Cd8+ T Cells in a Model for Multiple Sclerosis
Huseby, E. S., Liggitt, D., Brabb, T., Schnabel, B., Öhlén, C., & Goverman, J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.669 · Cited by 659
Separation of IL-4 Production from Th Cell Proliferation by an Altered T Cell Receptor Ligand
Evavold, B. D., & Allen, P. M. (1991) · Science · doi:10.1126/science.1833816 · Cited by 549
Zhang, J., Markovic-Plese, S., Lacet, B., Raus, J., Weiner, H. L., & Hafler, D. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.973 · Cited by 529
Serreze, D. V., Fleming, S. A., Chapman, H. D., Richard, S. D., Leiter, E. H., & Tisch, R. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.3912 · Cited by 456
Cited by
Items 101–200 of 223
Toward solving the etiological mystery of primary biliary cholangitis
Tanaka, A., Leung, P. S. C., Young, H. A., & Gershwin, M. E. (2017) · Hepatology Communications · doi:10.1002/hep4.1044 · Cited by 37
Self-citationAdvances in pharmacotherapy for primary biliary cirrhosis
Mousa, H. S., Lleò, A., Invernizzi, P., Bowlus, C. L., & Gershwin, M. E. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.998650 · Cited by 40
Self-citationT cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1
Zhang, W., Ono, Y., Miyamura, Y., Bowlus, C. L., Gershwin, M. E., & Maverakis, E. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.05.009 · Cited by 34
Self-citationBhandari, B. M., Bayat, H., & Rothstein, K. D. (2011) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2011.03.008 · Cited by 36
Ma, H.-D., Ma, W.-T., Liu, Q.-Z., Zhao, Z.-B., Liu, M.-Z.-Y., Tsuneyama, K., Gao, J.-M., Ridgway, W. M., Ansari, A. A., Gershwin, M. E., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.12.012 · Cited by 35
Self-citationAnimal Models of Autoimmune Liver Diseases: a Comprehensive Review
Liu, S.-P., Bian, Z.-H., Zhao, Z.-B., Wang, J., Zhang, W., Leung, P. S. C., Li, L., & Lian, Z. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08778-6 · Cited by 42
Self-citationConcepcion, A. R., Salas, J. T., Sáez, E., Sarvide, S., Ferrer, A., Portu, A., Uriarte, I., Hervás‐Stubbs, S., Elferink, R. P. J. O., Prìeto, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5665 · Cited by 35
The role of jo-1 in the immunopathogenesis of polymyositis: Current hypotheses
Ascherman, D. P. (2003) · Current Rheumatology Reports · doi:10.1007/s11926-003-0052-2 · Cited by 30
The autoimmunity of primary biliary cirrhosis and the clonal selection theory
Selmi, C. F., Mackay, I. R., & Gershwin, M. E. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.126 · Cited by 33
Self-citationPrimary biliary cirrhosis and autoimmune cholangiopathy
Vierling, J. M. (2004) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00132-6 · Cited by 31
Invernizzi, P., Alessio, M. G., Smyk, D. S., Lleo, A., Sonzogni, A., Fabris, L., Candusso, M., Bogdanos, D. P., Iorio, R., & Torre, G. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-92 · Cited by 28
Is primary biliary cirrhosis a model autoimmune disease?
Ichiki, Y., Shimoda, S., Ishibashi, H., & Gershwin, M. E. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.04.001 · Cited by 29
Self-citationPathophysiology of primary biliary cholangitis
Gulamhusein, A. F., & Hirschfield, G. M. (2018) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2018.05.012 · Cited by 35
Pathogenesis of primary biliary cirrhosis
Kita, H., Nalbandian, G., Keeffe, E. B., Coppel, R. L., & Gershwin, M. E. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00096-5 · Cited by 28
Self-citationCurrent Landscape and Evolving Therapies for Primary Biliary Cholangitis
Fiorucci, S., Urbani, G., Giorgio, C. D., Biagioli, M., & Distrutti, E. (2024) · Cells · doi:10.3390/cells13181580 · Cited by 31
Liu, Y., Dong, Y., Wu, X., Wang, X., & Niu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.918445 · Cited by 30
Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
Zein, C. O., & Lindor, K. D. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-009-0079-2 · Cited by 26
Promiscuous T cells selected by Escherichia coli: OGDC-E2 in primary biliary cirrhosis
Tanimoto, H., Shimoda, S., Nakamura, M., Ishibashi, H., Kawano, A., Kamihira, T., Matsushita, S., Gershwin, M. E., & Harada, M. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00024-6 · Cited by 25
Self-citationPrimary biliary cirrhosis: Past, present, and future
Kaplan, M. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.36373 · Cited by 26
Self-citationPalmer, J. M., Robe, A. J., Burt, A. D., Kirby, J. A., & Jones, D. E. (2004) · Hepatology · doi:10.1002/hep.20248 · Cited by 25
Innate immunity drives xenobiotic-induced murine autoimmune cholangitis
Chang, C.-H., Chen, Y.-C., Yu, Y.-H., Tao, M.-H., Leung, P. S. C., Ansari, A. A., Gershwin, M. E., & Chuang, Y.-H. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12298 · Cited by 25
Self-citationImmunologic Responses and the Pathophysiology of Primary Biliary Cholangitis
Chen, R., Tang, R., Ma, X., & Gershwin, M. E. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.06.003 · Cited by 28
Self-citationThe immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects
Ronca, V., Davies, S. P., Oo, Y. H., & Lleo, A. (2025) · Hepatology · doi:10.1097/hep.0000000000001225 · Cited by 22
Vaishnav, J., Khan, F., Yadav, M., PARMAR, N. R., Buch, H., Jadeja, S. D., Dwivedi, M., & Begum, R. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152274 · Cited by 25
Adam, L., Zoldan, K., Hofmann, M., Schultheiß, M., Bettinger, D., Neumann‐Haefelin, C., Thimme, R., & Boettler, T. (2018) · Hepatology Communications · doi:10.1002/hep4.1226 · Cited by 22
Ueno, Y., Moritoki, Y., Shimosegawa, T., & Gershwin, M. E. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2019-y · Cited by 24
Self-citationAntigen-specific T cells and autoimmunity
Rojas, M., Acosta‐Ampudia, Y., Heuer, L. S., Zang, W., Monsalve, D. M., Ramírez-Santana, C., Anaya, J., Ridgway, W. M., Ansari, A. A., & Gershwin, M. E. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103303 · Cited by 32
Self-citationImmune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers
Kremer, A. E., Rust, C., Eichhorn, P., Beuers, U. H., & Holdenrieder, S. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.9.2.139 · Cited by 24
Infectious Agents in the Pathogenesis of Primary Biliary Cirrhosis
Ortega‐Hernandez, O., Agmon‐Levin, N., Altman, A., & Shoenfeld, Y. (2010) · Disease Markers · doi:10.1155/2010/923928 · Cited by 19
Application of tetramer technology in studies on autoimmune diseases
Kita, H., He, X.-S., & Gershwin, M. E. (2003) · Autoimmunity Reviews · doi:10.1016/s1568-9972(02)00124-6 · Cited by 19
Self-citationCardon, A., Guinebretière, T., Dong, C., Gil, L., Ado, S., Gavlovsky, P.-J., Braud, M., Danger, R., Schultheiß, C., Doméné, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56363-2 · Cited by 27
Vanishing Bile Duct Syndrome in an Adult Patient: Case Report and Review of the Literature
Izzo, P., Gallo, G., Pisanelli, M. C., D’Onghia, G., Macci, L., Gabriele, R., Polistena, A., Izzo, L., Izzo, S., & Basso, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123253 · Cited by 18
Vanishing bile duct syndrome in human immunodeficiency virus: Nevirapine hepatotoxicity revisited
Kochar, R. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i26.3335 · Cited by 18
Autoimmune disease triggered by infection with alphaproteobacteria
Mohammed, J. P., & Mattner, J. (2009) · Expert Review of Clinical Immunology · doi:10.1586/eci.09.23 · Cited by 18
Primary Biliary Cholangitis in Males
Shaker, M., Mansour, N., & John, B. V. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.06.008 · Cited by 21
β-Glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis
Zhang, W., Moritoki, Y., Tsuneyama, K., Yang, G.-X., Ilan, Y., Lian, Z.-X., & Gershwin, M. E. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03971.x · Cited by 17
Self-citationObeticholic acid for the treatment of primary biliary cirrhosis
Jones, D. E. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2016.1216784 · Cited by 18
Bioinformatic approach for understanding the heterogeneity of cholangiocytes
Fukushima, K., & Ueno, Y. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i22.3481 · Cited by 15
Deng, C., Li, W., Fei, Y., Wang, L., Chen, Y., Zeng, X., Zhang, F., & Li, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01619 · Cited by 18
Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments
Trivedi, P. J., & Cullen, S. (2012) · Hepatology International · doi:10.1007/s12072-012-9362-7 · Cited by 19
Tetravalent anti-CD20/CD3 bispecific antibody for the treatment of B cell lymphoma
Lu, C.-Y., Chen, G. J., Tai, P., Yang, Y., Hsu, Y.-S., Chang, M., & Hsu, C.-L. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.124 · Cited by 16
Zen, Y., Hübscher, S. G., & Nakanuma, Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00009-1 · Cited by 25
Robe, A. J., Kirby, J. A., Jones, D. E., & Palmer, J. M. (2005) · Hepatology · doi:10.1002/hep.20642 · Cited by 16
Autoantibodies in Primary Biliary Cholangitis
Leung, K. K., & Hirschfield, G. M. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.06.004 · Cited by 17
Tewari, R., Yang, S. J., McClain, E. D., Hu, A. K., Mortensen, E., DeSchmidt, A. M., Chen, J., Kancharla, A., Singh, A. K., James, E. A., et al. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103327 · Cited by 18
Current concepts in the pathogenesis of primary biliary cirrhosis
Charatcharoenwitthaya, P., & Lindor, K. D. (2005) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32061-7 · Cited by 17
Primary biliary cirrhosis and liver transplantation
Akamatsu (2012) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2012.v1.2.66 · Cited by 26
Immune Checkpoints and the Immunology of Liver Fibrosis
Tsomidis, I., Voumvouraki, A., & Kouroumalis, E. (2025) · Livers · doi:10.3390/livers5010005 · Cited by 17
Yan, L., Zhu, Y., Zhou, L., Fang, Y., Huang, L., Ren, L., Peng, Y., Li, Y., Yang, F., Xie, D., et al. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.01.003 · Cited by 14
Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems
Wen, R. M., Umeano, A. C., Francis, L., Sharma, N. D., Tundup, S., & Dhar, S. (2016) · Vaccines · doi:10.3390/vaccines4020018 · Cited by 15
Zhang, W., Zhang, R., Zhang, J., Sun, Y. H., Leung, P. S. C., Yang, G., Shuai, Z., Ridgway, W. M., & Gershwin, M. E. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.149 · Cited by 14
Self-citationTanaka, H., Yang, G.-X., Tomiyama, T., Tsuneyama, K., Zhang, W., Leung, P. S. C., Coppel, R. L., Joh, T., Nadler, S., Ansari, A. A., et al. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12581 · Cited by 13
Self-citationPathogenesis of primary biliary cirrhosis: A unifying model
Kouroumalis, E., & Notas, G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i15.2320 · Cited by 13
Dysregulation of peritoneal cavity B1a cells and murine primary biliary cholangitis
Yang, Y., Yang, W., Yao, Y., Ma, H.-D., Wang, Y., Li, L., Wu, Q., Gershwin, M. E., & Lian, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.8853 · Cited by 13
Self-citationVanishing Bile Duct Syndrome Preceding the Diagnosis of Hodgkin Lymphoma
Anugwom, C. M., Goetz, G., & Hassan, M. A. S. (2020) · ACG Case Reports Journal · doi:10.14309/crj.0000000000000336 · Cited by 13
Zhang, S., Tao, X., Wang, L., Chen, H., Zhao, L., Sun, J., Bian, S., Chen, Z., Shao, T., Yang, Y., et al. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07165-1 · Cited by 14
Proposed therapies in primary biliary cholangitis
Floreani, A., Sun, Y. H., Zou, Z. S., Li, B., Cazzagon, N., Bowlus, C. L., & Gershwin, M. E. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1121810 · Cited by 14
Self-citationMawardi, M., Alalwan, A. M., Fallatah, H. I., Abaalkhail, F. A., Hasosah, M. Y., Shagrani, M. A., Alghamdi, M., & Alghamdi, A. (2021) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_112_21 · Cited by 14
Autoreactive CD8‐specific T‐cell response in primary biliary cirrhosis
Kita, H. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00238.x · Cited by 12
Self-citationKawano, A., Shimoda, S., Kamihira, T., Ishikawa, F., Niiro, H., Soejima, Y., Taketomi, A., Maehara, Y., Nakamura, M., Komori, A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3315 · Cited by 12
Self-citationJiang, T., Han, Z., Chen, S., Wu, C., Tang, Y., Qian, C., Chen, Y., Zhou, Y., Zhu, Y., Gu, M., et al. (2009) · Clinical and Experimental Medicine · doi:10.1007/s10238-009-0052-2 · Cited by 12
Primary Biliary Cirrhosis: Solving the Enigma
Giorgini, A., Selmi, C. F., Invernizzi, P., PODDA, M. U., Zuin, M. G., & Gershwin, M. E. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1361.060 · Cited by 14
Self-citationDetection of GAD65 Autoreactive T‐Cells by HLA Class I Tetramers in Type 1 Diabetic Patients
Giuliani, L., Mele, R., Giovine, M. D., Altieri, L., Crinò, A., Ravà, L., & Fierabracci, A. (2009) · BioMed Research International · doi:10.1155/2009/576219 · Cited by 12
Faisal, M. S., González, H. C., & Gordon, S. C. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.06.005 · Cited by 16
Conventional type 1 dendritic cells are essential for the development of primary biliary cholangitis
Reuveni, D., Assi, S., Gore, Y., Brazowski, E., Leung, P. S. C., Shalit, T., Gershwin, M. E., & Zigmond, E. (2024) · Liver International · doi:10.1111/liv.15961 · Cited by 11
Self-citationThe pathogenesis of primary biliary cirrhosis
Herruzo, J. A. S., Muñoz, P. S., & Yagüe, T. M. (2009) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082009000600007 · Cited by 12
Sasaki, M., Ikeda, H., Kataoka, H., & Nakanuma, Y. (2006) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-006-0257-7 · Cited by 12
Mackay, I. R. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00230.x · Cited by 11
Gill, D., & Tan, P. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.499360 · Cited by 15
Sun, K., Ma, S., Tian, S., Zhang, M., Liu, Y., Li, B., Zhou, X., Zheng, X., Zhou, X., Wang, L., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-2427 · Cited by 9
How, why, and when does primary biliary cirrhosis recur after liver transplantation?
Williams, R. L., & Gershwin, M. E. (2007) · Liver Transplantation · doi:10.1002/lt.21143 · Cited by 10
Self-citationNanjundappa, R. H., Christen, U., & Umeshappa, C. S. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000218 · Cited by 9
Nanjundappa, R. H., Shao, K., Krishnamurthy, P., Gershwin, M. E., Leung, P. S. C., & Umeshappa, C. S. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103485 · Cited by 10
Self-citationPrimary biliary cholangitis: review for radiologists
Morgan, M. A., & Sundaram, K. M. (2021) · Abdominal Radiology · doi:10.1007/s00261-021-03335-x · Cited by 9
Kita, H., Ansari, A. A., He, X.-S., Lian, Z., de Water, J. V., Coppel, R. L., Luketic, V. A., Kaplan, M., Inamori, H., Isoda, N., et al. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00089-1 · Cited by 9
Self-citationFeuth, T., van Baarle, D., Hoepelman, A. I. M., van Erpecum, K. J., Siersema, P. D., & Arends, J. E. (2014) · APOPTOSIS · doi:10.1007/s10495-014-0992-1 · Cited by 8
Selmi, C. F., & Gershwin, M. E. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_49 · Cited by 8
Self-citationPrimary biliary cirrhosis: for want of an X chromosome?
Kaplan, M. M., & Bianchi, D. W. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15576-1 · Cited by 8
Self-citationHuman leukocyte antigens among primary biliary cirrhosis patients born in Mexico
Vázquez‐Elizondo, G., Ponciano‐Rodríguez, G., Uribe, M., & Méndez‐Sánchez, N. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31808-3 · Cited by 7
Investigational farnesoid X receptor agonists for the treatment of primary biliary cholangitis
Akepati, P. R., & Gochanour, E. M. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2348743 · Cited by 8
Investigational drugs in phase II clinical trials for primary biliary cholangitis
Silveira, M. G., & Lindor, K. D. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1371135 · Cited by 6
Invernizzi, P., Leung, P. S. C., Ma, X., & Gershwin, M. E. (2013) · Springer eBooks · doi:10.1007/978-3-319-02096-9_18 · Cited by 5
Self-citationGenetics of Primary Biliary Cirrhosis
Mells, G. F., & Hirschfield, G. M. (2013) · Wiley eBooks · doi:10.1002/9780470015902.a0024406 · Cited by 6
Bioinformatic approach for cholangiocyte pathophysiology
Ueno, Y., Fukushima, K., Nakagome, Y., Kido, O., & Shimosegawa, T. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00233.x · Cited by 4
Shionoya, K., Kobayashi, M., Kako, M., Masuda, S., Makazu, M., & Koizumi, K. (2023) · Internal Medicine · doi:10.2169/internalmedicine.2427-23 · Cited by 4
Qian, C., Chen, S., Yao, D., Wu, C., Jiang, T., Ke, J., Zhou, Y., Gu, M., Chen, B., Deng, A., et al. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9207-2 · Cited by 3
Kaplan, M. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-378630-2.00086-4 · Cited by 4
Self-citationHuang, L.-X., Qiu, Z.-X., Wang, X., Wang, Z., & Feng, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-07311-z · Cited by 3
Selmi, C. F., Coppel, R. L., & Gershwin, M. E. (2006) · Elsevier eBooks · doi:10.1016/b978-012595961-2/50057-3 · Cited by 4
Self-citationHan, F., Fang, M.-X., Zhao, D., Dong, Y.-C., Yuan, G., Gao, J.-E., & Guo, C. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106393 · Cited by 3
Bergasa, N. V. (2021) · Springer eBooks · doi:10.1007/978-1-4471-4715-2_3 · Cited by 5
Animal Models for Primary Biliary Cirrhosis
Moritoki, Y., & Ueno, Y. (2014) · Springer eBooks · doi:10.1007/978-4-431-54789-1_14 · Cited by 3
Addisons’ other disease: primary biliary cirrhosis as a model autoimmune disease
Jones, D. E. J. (2003) · Clinical Medicine · doi:10.7861/clinmedicine.3-4-351 · Cited by 3
The significance of anti-nuclear envelope (gp210) antibody in primary biliary cirrhosis
Nakamura, M. (2005) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.28.117 · Cited by 3
Ma, H., Liu, Y., Zhu, Y., Xu, G. Q., Xiang, X., Xue, S., Zhang, Z., Cheng, C., Lu, F., Wang, B., et al. (2025) · Immunology Letters · doi:10.1016/j.imlet.2025.107100 · Cited by 3
CCL26 in primary biliary cholangitis – Is it a novel disease mediator?
Sun, X., Cao, Y., Wang, L., Chen, H., & Zhang, F. (2023) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.14578 · Cited by 2
Zen, Y., Hübscher, S. G., & Nakanuma, Y. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00009-0 · Cited by 3
Innate lymphoid cell subsets in the pathogenesis of primary biliary cholangitis
Liu, Y., Hu, Y., Li, B., Su, R. J., Han, Z., Jin, B., Li, T., Zheng, X., & Han, Y. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16547 · Cited by 2
Tanaka, A., Leung, P. S. C., Bowlus, C. L., & Gershwin, M. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_22 · Cited by 2
Self-citationMolecular Basis of Primary Biliary Cirrhosis
Bassendine, M. F. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9034-1_17 · Cited by 2
Metadata
- Authors
- Kita, H., Matsumura, S., He, X.-S., Ansari, A. A., Lian, Z.-X., Van de Water, J., Coppel, R. L., Kaplan, M. M., & Gershwin, M. E.
- Affiliations
- University of California, Davis (US)
- Emory University (US)
- Monash University (AU)
- Tufts Medical Center (US)
- Corresponding author
- Gershwin, M. Eric
- Venue
- Journal of Clinical Investigation
- Published
- 2002-05-01
- Volume
- 109
- Issue
- 9
- Pages
- 1231-1240
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4229877359
- Cited by
- 222
- References
- 38
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 8 · 2023: 7 · 2022: 9 · 2021: 10 · 2020: 10 · 2019: 5 · 2018: 7 · 2017: 9 · 2016: 6 · 2015: 10 · 2014: 11 · 2013: 12 · 2012: 6
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- primary biliary cirrhosis, PDC-E2, pyruvate dehydrogenase complex, CD8+ T cells, MHC class I epitopes, immunopathogenesis, interferon-gamma, autoantigen-specific T cells, CD4+ T cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.